Earnings Feed
Start Free
|4Feb 18, 8:56 PM ET

Allen Robert D. III 4

Research Summary

AI-generated summary

Updated

Invivyd (IVVD) CSO Robert D. Allen III Sells Shares

What Happened

  • Robert D. Allen III, Chief Scientific Officer of Invivyd (IVVD), had 99,000 restricted stock units (RSUs convert to common shares) vest/convert on Feb 15, 2026. To satisfy tax withholding, he sold 18,189 shares on Feb 17, 2026 for a weighted average price of $1.54 (≈ $28,004) and 19,392 shares on Feb 18, 2026 for a weighted average price of $1.58 (≈ $30,597), for total gross proceeds of about $58,601. The vesting/conversion of the RSUs is reported as an exercise/conversion transaction.

Key Details

  • Transaction dates and prices:
    • 2026-02-15: 99,000 RSUs converted to 99,000 shares (reported as exercise/conversion).
    • 2026-02-17: Sold 18,189 shares at a weighted avg $1.54 (sales executed at prices ranging $1.505–$1.590).
    • 2026-02-18: Sold 19,392 shares at a weighted avg $1.58 (sales executed at prices ranging $1.550–$1.595).
  • Total proceeds from open-market sales: ≈ $58,601.
  • Shares owned after the transactions: not specified in the Form 4 provided.
  • Notable footnotes:
    • F1/F5: Each RSU equals one share; this award vests over 18 months with one‑third vesting every 6 months from Feb 15, 2025.
    • F2: The open‑market sales were non‑discretionary sell‑to‑cover transactions under a Rule 10b5‑1 plan (adopted Feb 20, 2025) to satisfy tax withholding.
    • F3/F4: Reported sale prices are weighted averages; the filer will provide detailed per-trade prices on request.
  • Filing timeliness: Reported on Form 4 filed Feb 18, 2026 for transactions starting Feb 15, 2026 — appears timely (no late‑filing flag).

Context

  • These transactions are routine for RSU vesting: RSUs converted to shares and some shares were sold to cover taxes (sell‑to‑cover). Such sell‑to‑cover sales are generally administrative and do not necessarily indicate a change in the insider’s view of the company.
  • For retail investors, purchases are often more informative than routine sell‑to‑cover transactions. This filing reflects vesting and tax‑related sales rather than a discretionary sale for investment reasons.